Daewoong’s Nabota surpasses 1 trillion won in cumulative sales
AI Summary- Daewoong Pharmaceutical is expanding Nabota’s global partner training and marketing support.
- Nabota surpassed 1 trillion won in cumulative sales and targets 300 billion won annually.
- Nabota holds approvals in 69 countries and partnerships in about 80 countries.